Change starts here.
Drink alcohol often? You could qualify for a research study at NIDA.
We are seeking study participants who are at least 21 years old and drink alcohol.
Study Name
Spironolactone in Alcohol Use Disorder (SAUD): A double-blind, placebo-controlled, ascending dose, Phase 1b Study
Study# 001546-DA
Nickname: SAUD
Purpose
We are evaluating an FDA-approved drug called spironolactone. We want to understand how the body breaks down this drug and if there are any side effects in people who drink alcohol and take this drug.
Length of Study
4 1-week inpatient stays over the course of 2 months.
Study Activities
Taking a drug (spironolactone) and/or a placebo during visits, ETOH consumption, blood samples, and completing questionnaires.
Compensation
Up to $3,075.
Local Travel
Will be provided (via Uber Health) or reimbursed.
Call now for a confidential screening:
If right now isn't convenient:
More information about this study is available here.